Subsequently, ROC curve analysis showed that the AUC value for distinguishing AML patients from healthy controls based on FOXP1 expression was 0.684 [95% confidence interval (CI), 0.5573–0.8107] (P=0.008) (Figure 1E). Here, FOXP1 is linked to acute myeloid leukemia.